267 related articles for article (PubMed ID: 27130815)
1. Risks of Bleeding Recurrence and Cardiovascular Events With Continued Aspirin Use After Lower Gastrointestinal Hemorrhage.
Chan FK; Leung Ki EL; Wong GL; Ching JY; Tse YK; Au KW; Wu JC; Ng SC
Gastroenterology; 2016 Aug; 151(2):271-7. PubMed ID: 27130815
[TBL] [Abstract][Full Text] [Related]
2. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin.
Chan FK; Kyaw M; Tanigawa T; Higuchi K; Fujimoto K; Cheong PK; Lee V; Kinoshita Y; Naito Y; Watanabe T; Ching JY; Lam K; Lo A; Chan H; Lui R; Tang RS; Sakata Y; Tse YK; Takeuchi T; Handa O; Nebiki H; Wu JC; Abe T; Mishiro T; Ng SC; Arakawa T
Gastroenterology; 2017 Jan; 152(1):105-110.e1. PubMed ID: 27641510
[TBL] [Abstract][Full Text] [Related]
3. Reinitiating aspirin therapy for primary prevention of cardiovascular events in a patient post-aspirin-induced upper gastrointestinal bleed: a case report and review of literature.
Adly G; Plakogiannis R
Ann Pharmacother; 2013 Feb; 47(2):e8. PubMed ID: 23386069
[TBL] [Abstract][Full Text] [Related]
4. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
5. Aspirin for Primary Prevention of Cardiovascular Events.
Abdelaziz HK; Saad M; Pothineni NVK; Megaly M; Potluri R; Saleh M; Kon DLC; Roberts DH; Bhatt DL; Aronow HD; Abbott JD; Mehta JL
J Am Coll Cardiol; 2019 Jun; 73(23):2915-2929. PubMed ID: 31196447
[TBL] [Abstract][Full Text] [Related]
6. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial.
Sung JJ; Lau JY; Ching JY; Wu JC; Lee YT; Chiu PW; Leung VK; Wong VW; Chan FK
Ann Intern Med; 2010 Jan; 152(1):1-9. PubMed ID: 19949136
[TBL] [Abstract][Full Text] [Related]
7. Incidence of Upper and Lower Gastrointestinal Bleeding in New Users of Low-Dose Aspirin.
Cea Soriano L; Lanas A; Soriano-Gabarró M; García Rodríguez LA
Clin Gastroenterol Hepatol; 2019 Apr; 17(5):887-895.e6. PubMed ID: 29908361
[TBL] [Abstract][Full Text] [Related]
8. Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin.
Sørensen HT; Mellemkjaer L; Blot WJ; Nielsen GL; Steffensen FH; McLaughlin JK; Olsen JH
Am J Gastroenterol; 2000 Sep; 95(9):2218-24. PubMed ID: 11007221
[TBL] [Abstract][Full Text] [Related]
9. Minidose aspirin and gastrointestinal bleeding--a retrospective, case-control study in hospitalized patients.
Sapoznikov B; Vilkin A; Hershkovici M; Fishman M; Eliakim R; Niv Y
Dig Dis Sci; 2005 Sep; 50(9):1621-4. PubMed ID: 16133960
[TBL] [Abstract][Full Text] [Related]
10. Incidence and risk factors of gastrointestinal bleeding in patients on low-dose aspirin therapy after percutaneous coronary intervention in Japan.
Nadatani Y; Watanabe T; Tanigawa T; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Yoshiyama M; Arakawa T
Scand J Gastroenterol; 2013 Mar; 48(3):320-5. PubMed ID: 23298342
[TBL] [Abstract][Full Text] [Related]
11. Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies.
García Rodríguez LA; Martín-Pérez M; Hennekens CH; Rothwell PM; Lanas A
PLoS One; 2016; 11(8):e0160046. PubMed ID: 27490468
[TBL] [Abstract][Full Text] [Related]
12. A case-control study of the association between polymorphisms of the endothelial nitric oxide synthase and glycoprotein IIIa genes and upper gastrointestinal bleeding in users of low-dose aspirin.
Piazuelo E; Fuentes J; García-González MA; Jiménez P; Lanas A
Clin Ther; 2008 Jan; 30(1):121-30. PubMed ID: 18343248
[TBL] [Abstract][Full Text] [Related]
13. [Risk factors for gastrointestinal bleeding associated with low-dose aspirin].
Sibilia J; Ravaud P; Marck G
Presse Med; 2003 Nov; 32(37 Pt 2):S9-16. PubMed ID: 14763349
[TBL] [Abstract][Full Text] [Related]
14. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.
Chan FK; Chung SC; Suen BY; Lee YT; Leung WK; Leung VK; Wu JC; Lau JY; Hui Y; Lai MS; Chan HL; Sung JJ
N Engl J Med; 2001 Mar; 344(13):967-73. PubMed ID: 11274623
[TBL] [Abstract][Full Text] [Related]
15. Reduced risk of gastrointestinal bleeding associated with eupatilin in aspirin plus acid suppressant users: nationwide population-based study.
Lee HS; Nam JH; Oh DJ; Moon YR; Lim YJ
Korean J Intern Med; 2024 Mar; 39(2):261-271. PubMed ID: 38092556
[TBL] [Abstract][Full Text] [Related]
16. [Digestive and hemorrhage complications of low-dose aspirin].
Sibilia J; Ravaud P; Marck G
Presse Med; 2003 Nov; 32(37 Pt 2):S17-28. PubMed ID: 14763350
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
Turajane T; Wongbunnak R; Patcharatrakul T; Ratansumawong K; Poigampetch Y; Songpatanasilp T
J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S19-26. PubMed ID: 20128070
[TBL] [Abstract][Full Text] [Related]
18. Incidence of gastrointestinal bleeding in patients with cardiovascular disease: buffered aspirin versus enteric-coated aspirin.
Hirata Y; Kataoka H; Shimura T; Mizushima T; Mizoshita T; Tanida S; Kamiya T; Joh T
Scand J Gastroenterol; 2011 Jul; 46(7-8):803-9. PubMed ID: 21501103
[TBL] [Abstract][Full Text] [Related]
19. Risk of gastrointestinal bleeding and benefit from colorectal cancer reduction from long-term use of low-dose aspirin: A retrospective study of 612 509 patients.
Tsoi KK; Chan FC; Hirai HW; Sung JJ
J Gastroenterol Hepatol; 2018 Oct; 33(10):1728-1736. PubMed ID: 29665624
[TBL] [Abstract][Full Text] [Related]
20. Primary non-variceal upper gastrointestinal bleeding in NSAID and low-dose aspirin users: development and validation of risk scores for either medication in two large Dutch cohorts.
de Groot NL; Hagenaars MP; Smeets HM; Steyerberg EW; Siersema PD; van Oijen MG
J Gastroenterol; 2014 Feb; 49(2):245-53. PubMed ID: 23609946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
